Fortis Healthcare has announced the grant of up to 1,32,05,200 stock options to eligible employees under its Employee Stock Option Scheme 2026. Each option entitles the holder to one fully paid-up equity share with a face value of ₹10, subject to SEBI regulations.
The Nomination & Remuneration Committee approved the grant at its meeting on April 23, 2026. The options are exercisable into an equivalent number of equity shares, with the exercise price set at ₹923.10 per option, based on the closing price on the stock exchange with the higher trading volume as of April 22, 2026.
The scheme complies with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The vesting period for the options is subject to a schedule and conditions approved by the Nomination & Remuneration Committee, with a maximum vesting period of three years from the date of grant.
The exercise period for vested options is set at a maximum of four years from the date of each vesting. As of now, the options have not been vested or exercised, and no money has been realised from the exercise of options. Further details, including options lapsed and diluted earnings per share, are not applicable at this stage.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).